Fact sheet: JPM Gbl Healthcare

Fund information

Fund name
JPM Global Healthcare A Acc NAV USD
Fund company manager
JPMorgan Asset Mgmt (Europe) S
Fund type
SIB
Fund manager(s)
Anne Marden
since 20/10/2009
Matthew Cohen
since 05/01/2015
Fund objective
To achieve a return by investing primarily in pharmaceutical, biotechnology, healthcare services, medical technology and life sciences companies ("Healthcare Companies"), globally.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Quick stats

1 Year return

24.64 %

1 Year rank in sector

11/30

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 2.8 b

FE Risk score

147

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • North America
    74.2%
  • Europe & Middle East
    18.3%
  • UK
    5.4%
  • Japan
    1.7%
  • Money Market
    0.4%
  • Biotechnology/Medical
    49.3%
  • Pharmaceuticals
    31.2%
  • Health Care
    19.1%
  • Money Market
    0.4%
  • North American Equities
    72.9%
  • International Equities
    17.7%
  • UK Equities
    5.6%
  • Money Market
    2.1%
  • Japanese Equities
    1.7%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund6.6 %6.49 %24.64 %7.37 %97.81 %
Sector5.27 %3.96 %18.74 %11.82 %99.64 %
Rank within sector13 / 3110 / 3111 / 3017 / 2712 / 23
Quartile th2 nd2 nd2 nd3 rd3 rd

Calendar performance

YTD-20182017201620152014
Fund5.32 %20.08 %-15.42 %2.14 %22.01 %
Sector5.4 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector18 / 3111 / 3022 / 3022 / 2719 / 24
Quartile th3 rd2 nd3 rd4 th4 th

Risk statistics

Alpha-1.92
Beta0.9
Sharpe-0
Volatility14.14
Tracking error4.12
Information ratio-0.54
R-Squared0.93

Price movement

52 week high317.56
52 week low252.46
Current bid price0
Current offer price0
Current mid price317.56

Holdings by region

  • 74.2% North America
  • 18.3% Europe & Middle East
  • 5.4% UK
  • 1.7% Japan
  • 0.4% Money Market

Holdings by sector

  • 49.3% Biotechnology/Medical
  • 31.2% Pharmaceuticals
  • 19.1% Health Care
  • 0.4% Money Market

Holdings by asset type

  • 72.9% North American Equities
  • 17.7% International Equities
  • 5.6% UK Equities
  • 2.1% Money Market
  • 1.7% Japanese Equities

Individual holdings

  • 7.7% UNITEDHEALTH GROUP INC
  • 4.9% ROCHE HLDG AG
  • 4% BRISTOL MYERS SQUIBB SA
  • 3.5% BAYER AG
  • 3% JOHNSON & JOHNSON
  • 2.9% CELGENE CORP
  • 2.8% VERTEX PHARMACEUTICAL
  • 2.7% PFIZER INC
  • 2.6% BIOGEN INC
  • 2.6% LILLY (ELI) & CO